1970EndocrinologyRequires access

Insulinotropic and Possible Insulin-like Effects of Secretin and Cholecystokinin-Pancreozymin

Z. Glick, Clifton A. Baile, Jean Mayer

Open publisher page 14 citations

Abstract

The effect of intravenous injection of secretin and cholecystokinin-pancreozymin (C-P) on serum immunoreactive insulin (IRI) in monkeys and rats was measured. Both secretin (7.5 U) and C-P (30 U) injections caused 4- to 5-fold increases in serum IRI of monkeys within 2 min. Only C-P (2 U) injections caused an increase (about 4-fold) in serum IRI of rats, while after secretin (0.5 U) injections there was no change in IRI. The serum glucose decreased in the monkeys following the increased IRI, but in neither species did serum glucose increase and therefore glucose was not the cause of the IRI response. In a separate experiment it was shown that neither secretin nor C-P increases appreciably the glucose uptake of isolated fat cells from epididymal fat pads of rats. (Endocrinology86: 927, 1970)

About this research paper

What this paper is about

The effect of intravenous injection of secretin and cholecystokinin-pancreozymin (C-P) on serum immunoreactive insulin (IRI) in monkeys and rats was measured. Both secretin (7.5 U) and C-P (30 U) injections caused 4- to 5-fold increases in serum IRI of monkeys within 2 min. Only C-P (2 U) injections caused an increase (about 4-fold) in serum IRI of rats, while after secretin (0.5 U) injections there was no change in IRI. The serum glucose decreased in the monkeys following the increased IRI, but in neither species did serum glucose increase and therefore glucose was not the cause of the IRI response. In a separate experiment it was shown that neither secretin nor C-P increases appreciably the glucose uptake of isolated fat cells from epididymal fat pads of rats. (Endocrinology86: 927, 1970)

Why it matters

OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The effect of intravenous injection of secretin and cholecystokinin-pancreozymin (C-P) on serum immunoreactive insulin (IRI) in monkeys and rats was measured. Both secretin (7.5 U) and C-P (30 U) injections caused 4- to 5-fold increases in serum IRI of monkeys within 2 min. Only C-P (2 U) injections caused an increase (about 4-fold) in serum IRI of rats, while after secretin (0.5 U) injections there was no change in IRI. The serum glucose decreased in the monkeys following the increased IRI, but in neither species did serum glucose increase and therefore glucose was not the cause of the IRI response. In a separate experiment it was shown that neither secretin nor C-P increases appreciably the glucose uptake of isolated fat cells from epididymal fat pads of rats. (Endocrinology86: 927, 1970)

Key concepts: Secretin, Internal medicine, Endocrinology, Cholecystokinin, Insulin, Chemistry, Medicine, Pancreas

Related papers

Back to paper searchBrowse research topicsOriginal source
Insulinotropic and Possible Insulin-like Effects of Secretin and Cholecystokinin-Pancreozymin — Research Paper | ScholarLens